1. Home
  2. DNUT vs ZURA Comparison

DNUT vs ZURA Comparison

Compare DNUT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.84

Market Cap

541.3M

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.69

Market Cap

435.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
ZURA
Founded
1937
2022
Country
United States
United States
Employees
N/A
30
Industry
Food Chains
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.3M
435.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DNUT
ZURA
Price
$3.84
$6.69
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$4.78
$11.78
AVG Volume (30 Days)
1.7M
466.6K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
1.17%
N/A
EPS Growth
108.70
N/A
EPS
N/A
N/A
Revenue
$1,665,397,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.58
$0.99
52 Week High
$6.51
$7.19

Technical Indicators

Market Signals
Indicator
DNUT
ZURA
Relative Strength Index (RSI) 69.16 60.81
Support Level $3.00 $5.62
Resistance Level $3.89 $6.76
Average True Range (ATR) 0.15 0.47
MACD 0.09 0.02
Stochastic Oscillator 76.40 68.75

Price Performance

Historical Comparison
DNUT
ZURA

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: